Diasome Pharmaceuticals, Inc.

New Filing
CIK: 0001411617·Biotechnology·DELAWARE·Filed: Sep 8, 2022
Total Offering

$19,092,510

Amount Sold

$16,724,591

Investors

40

First Sale

Aug 26, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Geho
Related Person
W. Blair Geho
Related Person
THOMAS MCDONALD
Related Person
Frank McCaney
Related Person
Marc Penn
Related Person

Company

Diasome Pharmaceuticals, Inc.

10000 CEDAR AVENUE

CLEVELAND, OH, 44106

216-444-7110

SEC Filing

0001411617-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Diasome Pharmaceuticals, Inc. Form D Filing — $19,092,510 | FilingFlow